Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
53.82x
As of Sep 29, 2023
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Sep 29, 2023 | 53.82x |
| Sep 28, 2023 | 53.40x |
| Sep 27, 2023 | 54.19x |
| Sep 26, 2023 | 57.51x |
| Sep 25, 2023 | 59.63x |
| Sep 22, 2023 | 62.56x |
| Sep 21, 2023 | 64.65x |
| Sep 20, 2023 | 64.47x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison